DR. OZ on Actipatch ( 10 years ago, go to 6:25 mark ), listen and weep!!!!!!!! https://www.youtube.com/watch?v=qVvS2dC2-1s Now, that Dr. Oz is Tsar.......BIEL...$$$$$$$$$$$$$$$$$$$$$!!!!!!!!!!!!!!!!!!!!!!!
RecoveryRx now available through prosthetics for pain management, ortho, PT Veterans Health Administration VA providers now have access to recently FDA-approved non-opioid, non-invasive pain management device through RecoveryRx. RecoveryRx produces an electromagnetic field at the point of pain that changes how cells communicate pain. Research, technical information and studies available at www.RecoveryRx.co. It is an amazing device, unlike TENS units, RecoveryRx reduces pain without any kind of electrical stimulation feeling for the veteran. The antenna lasts 30 days, all Ortho, pain management, and PT providers can work through prosthetics (RecoveryRx is on the FSS) to get these on their patients for feedback and widespread use at the VA.
No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( for like 13 years, from Oct. 2011 and counting?? ), did/will do any desired effect !!!!! We know they are watching BASHING work here, before the checks are being cut!!!
Australia LMT ActiPatch RecoveryRx www.actipatch.com.au Bangladesh Multiple Health Pharma ActiPatch Bahrain STADA ActiPatch www.stada.com Botswana Adcock Ingram ActiPatch www.actipatch.co.za China CICD ActiPatch Finland Kir Fix Oy ActiPatch www.kir-fix.fi Iran Al Mutawafiqua Modern Drug ActiPatch Ireland Inish Pharmacy ActiPatch www.inishpharmacy.com Italy OneGlobe Bio ActiPatch/RecoveryRx www.oneglobebio.com Jordan Al Mutawafiqua Modern Drug ActiPatch Kuwait Modern Development ActiPatch/RRx www.mdmedical.co Lebanon Al Mutawafiqua Modern Drug ActiPatch Mexico Novro Med S.A. de C.V. RecoveryRxhttps://globaltech.com.mx/ Oman Modern Development ActiPatch/RRx www.mdmedical.co Qatar Modern Development ActiPatch/RRx www.mdmedical.co Saudi Arabia STADA ActiPatch www.stada.com Spain Acuna Fombona ActiPatch www.acuna-fombona.com Spain PRIM Group RecoveryRx www.prim.es South Africa Adcock Ingram ActiPatch www.actipatch.co.za Sweden Swedish Healthcare Academy ActiPatch www.actipatch.se Taiwan Aphrodite Bio-Medical Technology ActiPatch www.abmt.com.tw UAE Modern Development RecoveryRx www.mdmedical.co United Kingdom Chemist4u ActiPatch www.chemist-4-u.com/ United States BioElectronics Corp RecoveryRx www.recoveryrx.co/ United States DonJoy DonJoy Advantage www.donjoyperformance.com Yemen Al Mutawafiqua Modern Drug ActiPatch
pps > .001 after management drops some positive hint(s) - Golden Cross (already achieved) and Blue Sky Breakout gets technicians/chartists attention and pps out of the trips;
pps > .01 after management drops positive hint(s) convincing investors that break even cash flow positive (annual rev = $1.5 mil) will be achieved, along with the momentum from a 2021 like OTC run (Reddit crowd takes notice);
pps > .04 after pr indicates annual revs from Taiwan (in progress) can be valued at $10 mil;
pps > .08 after pr indicates annual revs from VA (in progress) can be valued at $10 mil;
pps > .12 after pr indicates annual revs from RecoveryRx Veterinary (pending) can be valued at $10 mil;
pps > .16 after pr indicates annual revs from new contracts (distributors, partners, etc.) can be valued at $10 mil;
Lets see how high our beloved BIEL gets TRUMPed/JFK JUNIORed/DR. OZed up by Jan. 1, before NOPAIN Act is activated ( and, specifically, after!!! ) !!!!!
ATTENTION all the Respected, Smart, Intelligent Investors !!!!!!! Do your OWN, INTELLIGENT, THOROUGH DD, withoutANY INFLUENCE FROM KNOWN PAID BASHERS / PUMPERS / LIARS / MANIPULAYTORS / MISINFORMERS !!!!!!!!! Make sure, if you decide to invest ( and to decide you MUST !! ) :
#1 -- Don't put all the money you are willing to invest in one basket ( buy only one stock ), be diverse......VERY IMPORTANT -- Do your OWN, INTELLIGENT DD !!!!!!!!!!!!!!!!
#2 -- If you decide/willing to buy BIEL shares, know, that this is a HIGH RETURN / HIGH LOSS RISK ratio, but a MIRACLE PRODUCT ( ACTIPATCH ) is the key !!!!
#3 -- if you decide/willing to buy BIEL shares, invest only as much as you are willing to loose, without being hurt, FINANCIALLY !!!!!!!!!!!!!!!!!
Good luck to all !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Here are the HARD FACTS about Bioelectronics corp ( BIEL ). below , backed by LINKS, NOT some made up LIES, BS WORD SALADS, SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS to DAMAGE one's IMAGE, to INFLUENCE POTENTIAL Investors to think negative about the Company's ( BIEL ) Future, to FALL for WORD SALADS of SCARE TACTICS, with an AGENDA !!!!!!!!!!! BIEL$$$
------------------------------------------------------------------------------------------------------------------------------------------- "If you’re looking for a powerful way to enhance your vitality, recover faster, and optimize your overall well-being, I highly recommend exploring PEMF therapy. It’s an investment in your health and a key component of my own personal journey towards peak performance.”
– Tony Robbins
Tony uses a high powered $25,000 PEMF machine but anyone can sample some of PEMF's capabilities with a $30 ActiPatch.
(G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.— “(i) IN GENERAL.—
Notwithstanding any other provision of this subsection, with respect to a covered OPD service (or group of services) furnished on or after January 1, 2022, and before January 1, 2027, the Secretary shall not package, and shall make a separate payment as specified in clause (ii) for, a non-opioid treatment (as defined in clause (iii)) furnished as part of such service (or group of services).
“(ii) AMOUNT OF PAYMENT.— The amount of the payment specified in this clause is, with respect to a non-opioid treatment that is—
“(I) a drug or biological product, the amount of payment for such drug or biological determined under section 1847A; or
II) a medical device, the amount of the hospital’s charges for the device, adjusted to cost.
“(iii) DEFINITION OF NON-OPIOID TREATMENT. A ‘non-opioid treatment’ means—
“(I) a drug or biological product that is indicated to produce analgesia without acting upon the body’s opioid receptors; or
“(II) an implantable, reusable, or disposable medical device cleared or approved by the Administrator for Food and Drugs for the intended use of managing or treating pain;
that has demonstrated the ability to replace, reduce, or avoid opioid use or the quantity of opioids prescribed in a clinical trial or through data published in a peer-reviewed journal.”.>>>>
Ambulatory Surgical Center Payment System.—Section 1833(i)(2)(D) of the Social Security Act (42 U.S.C. 1395l(i)(2)(D)) is amended—
(1) by aligning the margins of clause (v) with the margins of clause (iv);
(2) by redesignating clause (vi) as clause (vii); and
(3) by inserting after clause (v) the following new clause:
“(vi) In the case of surgical services furnished on or after January 1, 2022, and before January 1, 2027, the payment system described in clause (i) shall provide, in a budget-neutral manner, for a separate payment for a non-opioid treatment (as defined in clause (iii) of subsection (t)(16)(G)) furnished as part of such services in the amount specified in clause (ii) of such subsection.”.
(c) Evaluation Of Therapeutic Services For Pain Management.— 1) REPORT TO CONGRESS.—
Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services (in this subsection referred to as the “Secretary”), acting through the Administrator of the Centers for Medicare & Medicaid Services, shall submit to Congress a report identifying—
(A) limitations, gaps, barriers to access, or deficits in Medicare coverage or reimbursement for restorative therapies, behavioral approaches, and complementary and integrative health services that are identified in the Pain Management Best Practices Inter-Agency Task Force Report and that have demonstrated the ability to replace or reduce opioid consumption; and
(B) recommendations to address the limitations, gaps, barriers to access, or deficits identified under subparagraph (A) to improve Medicare coverage and reimbursement for such therapies, approaches, and services.>>>>
(2) PUBLIC CONSULTATION .—In developing the report described in paragraph (1), the Secretary shall consult with relevant stakeholders as determined appropriate by the Secretary.
(3) EXCLUSIVE TREATMENT. —Any drug, biological product, or medical device that is a non-opioid treatment (as defined in section 1833(t)(16)(G)(iii) of the Social Security Act, as added by subsection (a)) shall not be considered a therapeutic service for the purpose of the report described in paragraph (1). ___________________________________________________________________
The Pain Relief Therapy Market is characterized by a diverse competitive landscape, with several leading companies influencing market trends and driving innovation. Notable players include:
Stimwave: Specializes in innovative neuromodulation devices designed for chronic pain management, focusing on minimally invasive procedures to enhance patient outcomes.
Merk & co: A global leader in pharmaceutical products, Merck is actively involved in developing new analgesics and expanding its portfolio to address unmet medical needs in pain management.
Sanofi: Known for its wide range of pharmaceutical products, Sanofi is committed to advancing pain relief therapies through research and strategic partnerships.
Endo Pharmaceuticals.: Focused on pain management solutions, Endo is leveraging its expertise to develop unique formulations that cater to varying patient needs.
Calmare Therapeutics: Recognized for its innovative non-invasive pain relief technology, Calmare Therapeutics is pioneering new approaches to chronic pain treatment.
Johnson & Johnson: A key player in the healthcare sector, Johnson & Johnson is expanding its pain relief offerings through a combination of product innovation and strategic acquisitions.
Abbott: Engaged in developing advanced pain relief systems, Abbott is at the forefront of creating integrated solutions that combine medical devices and pharmaceuticals.
Allergan: Known for its aesthetic and therapeutic products, Allergan is also exploring pain relief therapies, particularly in the realm of nerve block techniques.
Beiersdorf: While primarily recognized for its skincare products, Beiersdorf is venturing into the pain relief market with topical analgesics and other innovative solutions.
Hisamitsu.: A leader in transdermal drug delivery systems, Hisamitsu is focused on developing patch-based pain relief solutions.
UltraCare Pro: Specializes in therapeutic modalities that enhance pain management through non-invasive techniques.
Iskra Medical.: Develops medical devices that facilitate pain relief, particularly in physiotherapy and rehabilitation settings.
Bioelectronics Corp: Innovates in the field of electroceuticals, offering non-drug solutions for pain management .
Medline : A major player in the healthcare supply chain, Medline is expanding its product offerings to include pain management solutions.
Pfizer: Actively involved in researching and developing new pain relief medications to address chronic pain issues.
Each of these companies plays a vital role in shaping the Pain Relief Therapy Market through product innovations, market expansions, and strategic partnerships, contributing to the overall growth and development of the sector.
Moreover, consumer awareness regarding pain management options is on the rise. Patients are becoming more informed about their choices, leading to increased demand for customized solutions that cater to individual needs. This trend is prompting companies to focus on product customization and the development of tailored therapies.
Emerging technologies, such as wearable devices and Internet of Things (IoT) solutions, are also shaping the future of the Pain Relief Therapy Market. These innovations allow for continuous monitoring of patients' conditions, enabling timely interventions and adjustments to treatment plans based on real-time data. https://www.openpr.com/news/3785778/pain-relief-therapy-market-industry-dynamics-and-contributions
CONCLUSION "The medical device market is poised for significant growth across all major regions, driven by technological advancements, increasing healthcare spending, and a global focus on improving healthcare outcomes. London and the UK continue to position themselves as leaders in medical device innovation, while Europe remains a regulatory-driven but stable market. Asia offers the most dynamic growth opportunities, with countries like China and India playing pivotal roles. Meanwhile, the USA maintains its dominance as the largest medical device market, supported by advanced R&D and regulatory frameworks. Investors looking to capitalize on these trends should consider region-specific opportunities, keeping an eye on the evolving regulatory landscapes and technological innovations shaping the industry." https://iotworldmagazine.com/2024/09/05/2420/a-review-of-medical-device-market-size-reports-2024-2025-in-london-u-europe-asia-and-usa-focused-on-growth-forecast-and-segments
Globe Newswire via NewsMeiaWire Sree Koneru, PhD Joins the Board of BioElectronics Corporation FREDERICK, MD December 3, 2024 -- (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces that Sree Koneru, PhD, will join its Board of Directors, effective December 3, 2024. Upon Dr. Koneru’s appointment, the Board will consist of three members, including Kelly Whelan, President of BioElectronics, and its Chairman, Richard Staelin, PhD. https://www.facebook.com/story.php?story_fbid=1120914580039912&id=100063641406505 ___________________________________________________
PUBLISHED MAY 21, 2024 8:09AM EDT Non-Invasive Device Addresses the Treatment of Chronic Inflammation
FREDERICK, MD - (NewMediaWire) - May 21, 2024 - BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the filing of a new USPTO utility patent application addressing the treatment of chronic inflammation. This patent application, numbered 18/667,971, was a collaborative effort of John Martinez, Kenneth McLeod, PhD, and Richard Staelin, PhD. It outlines methods, systems, apparatuses, and devices that modify the immune response through non-invasive stimulation of the vagal nerves. The application draws from the results of a recently completed double-blind, placebo-controlled, canine study, published in Veterinary Medicine and Science which demonstrated that Pulsed Short Wave Therapy (PSWT) Technology applied to the vagal nerves of dogs diagnosed with osteoarthritis resulted in significant reductions in systemic discomfort.
Veterans, connect with us to learn more about RecoveryRx® New PAIN RELIEF TECHNOLOGY at the push of a button!!! https://kellycovemobility.com/rrx/
BIEL$$$ RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!! https://youtu.be/jljs7QPX7KE
MD Medical MD Medical is the fastest growing medical company in kuwait. SIster Company @socheck_kuwait Kuwait, Hawally Governorate, Salmiya, Block 2, Abdullah Bin Masoud Street, Al-Ras Tower, Floor 3, Office No.B3, Kuwait City 13091 https://www.instagram.com/mdmedicalco/ ___________________________________________________________
News BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says Staff Writer February 26, 2024
Veterans, connect with us to learn more about RecoveryRx® New PAIN RELIEF TECHNOLOGY at the push of a button!!! https://kellycovemobility.com/rrx/
BIEL$$$ RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!! https://youtu.be/jljs7QPX7KE ________________________________________________
A study investigating the efficacy of our FDA-cleared (human use) pulsed-shortwave-therapy (PSWT) device in initiating a systemic anti-inflammatory response to improve the functionality of canines diagnosed with osteoarthritis. 96% of the treatment group showed either increased passive range of motion, improved behavioral changes, or both compared to 4% for the placebo group. It was published today online in "Veterinary Medicine and Science." Medical professionals can contact us at info @newbie00 to request sample products. Pulsed shortwave electromagnetic field therapy increases quality of life in canines with symptoms of osteoarthritics Tanya Ella Sprunks, Kenneth J. McLeod, Richard Staelin First published: 22 March 2024 https://doi.org/10.1002/vms3.1408 Sree Koneru and Jack Merrifield contributed equally to this study. https://onlinelibrary.wiley.com/doi/10.1002/vms3.1408
Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness. Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions. https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst
"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy." https://www.glebevets.co.uk/services/physiotherapy/
Veterans, connect with us to learn more about RecoveryRx® New PAIN RELIEF TECHNOLOGY at the push of a button!!! https://kellycovemobility.com/rrx/
BIEL$$$ RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!! https://youtu.be/jljs7QPX7KE
Once, pay ATTENTION Everyone -- NOT if, imo, NHL, NFL, NBA, WBA, MLB, PGA, Lacrosse, etc...... adopts Actipatch as a must protocol, after all those HITS, CHECKS, TRIPS, LIGAMENT PULLS/RIPS, etc.......Possibilities are ENDLESS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!! ActiPatch® technology, your best ally ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints. https://gymprotips.com/tips-to-speed-recovery-from-injury/
------------------------------------------------------------------------------------------------- Actipatch ranked #1 in NASA Electromagnetic Pain Relief/Blocking: Feasibility Assessment !!!!!!!!
National Aeronautics and Space Administration Lyndon B. Johnson Space Center Houston, Texas 77058 ( pages 14, 15 )........
Context/Background:
Astronauts use pharmaceuticals during spaceflight to manage acute and chronic pain, but use of analgesics will have drawbacks for exploration-class missions because the shelf life of these medications is limited, resupply will be curtailed, astronauts may develop tolerance and/or addiction to these medications, and side effects can include impairment of cognitive abilities. Electromagnetic devices have been developed that treat pain terrestrially by affecting neuromodulation–dubbed “electroceuticals”, these devices have varied mechanisms of action that either stimulate or suppress neural activity in the central nervous system or peripheral nerves.
Objective/Purpose: The available literature was reviewed and FDA-approved pain treatments (both pharmacological and non-pharmacological), as well as those currently under development, were assessed for their suitability for use in exploration class spaceflight missions.
Results: An overwhelming majority of the literature focuses on the treatment of chronic rather than acute pain because it is assumed that acute pain only rarely fails to resolve and instead transitions into chronic pain when the central nervous system becomes hypersensitized. The available electromagnetic devices marketed for pain treatment have varying levels of invasiveness, use different mechanisms of action, and have demonstrated varying efficacy when evaluated scientifically. A truly noninvasive, highly efficient device is desired for use during spaceflight. One portable, self-contained, FDA-approved device was identified that, from preliminarily assessment, best met these criteria; the device noninvasively applies pulsed shortwave therapy (PSWT) to modify pain signals from peripheral nerves, however, the device has limited battery life and the effects are relatively non-selective in type of neural signal modified.
Ranking: The treatment method ranked first in this review was pulsed shortwave therapy (PSWT), a low-power RF (MHz range) transmitter operated adjacent to biological tissue at maximum output (saturation) to modulate peripheral nerve activity. ActiPatch is a very small wearable PSWT device that is FDA approved for “adjunctive treatment of musculoskeletal pain” [Anwar-Deen 2020]. It is low cost, low power, and boasts 97% efficacy in reducing pain (85% over a 6-month period) [Staelin 2019]. The device can be secured to the body by physio tape and the area causing pain is bounded by the device’s ring. The device can be turned on and off, and the non-rechargeable battery is capable of 720 hours of operation (one month continuous use). ActiPatch is sold OTC in local pharmacies for ~$30 [ActiPatch 2020].
Conclusions: The information obtained in the execution of this review effort leads to 2 recommendations for forward work: 1. Tie into DoD and NIH research funding efforts to improve pain treatment: the NIH has a federal partners workgroup for their HEAL Initiative that could conceivably be joined by NASA, and the DoD CPMRP’s initial solicitation only recently completed so that program is young and potentially synergies could be identified with NASA.
2. Obtain an ActiPatch device for evaluation and determine whether it could be beneficial and adapted to spaceflight use.
INTRODUCING RecoveryRx Veterinary Drug-Free Pain Relief Device For Indoor and Outdoor Pets https://rrxvet.carrd.co/ BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Vet Recovery RX "An innovation in drug-free pain and edema management. RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy device which utilizes radio-frequency electromagnetic energy to modulate nerve activity" https://vetphysiodevon.com/vet-recoverry rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity
Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness. Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions. https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst
Veterans, connect with us to learn more about RecoveryRx® New PAIN RELIEF TECHNOLOGY at the push of a button!!! https://kellycovemobility.com/rrx/
BIEL$$$ RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!! https://youtu.be/jljs7QPX7KE
"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy." https://www.glebevets.co.uk/services/physiotherapy/
Skymedicalsupply •skymedicalsupply's profile picture Introducing the EME BACK WRAP with ActiPatch® Technology, a revolutionary pain relief solution for your back. This innovative wrap utilizes ActiPatch® technology, clinically proven to alleviate pain by regulating the activity of sensitized nerves and reducing abnormal pain signaling. With its ability to deliver 1,000 sensation-free electromagnetic pulses per second, this wrap offers effective relief for up to 720 hours. https://www.instagram.com/skymedicalsupply/p/C6J0wXQCGLF/ ___________________________________________________________
Welcome to the largest health and beauty store in Europe! PromoFarma is the marketplace which groups the catalogues from more than 1.000 pharmacies and other sellers into one single website, selects the basket of products at the best price, collects the order from the selected pharmacies and delivers it wherever you want. ActiPatch effective knee-pain relief !!!!!!!! https://www.promofarma.com/en/actipatch-effective-knee-pain-relief-1pc/p-552091
____________________________________________________________ CHEMIST4u ( UK ) ActiPatch Muscle and Joint Pain Therapy Devices https://www.chemist-4-u.com/brands/actipatch?fbclid =IwAR21Sy7YpQYVw-otDE2ah9aPf-DNslt0jUw4xJMFcKxAXRyo_JkWNQ7TcYI
____________________________________________
ActiPatch is the drug-free solution for pain. It interrupts abnormal pain signaling in the nerves. You won't feel anything but relief. $$$ BACK GUARANTEE USA: http://actipatch.com 📷
ActiPatch® @ActiPatch ActiPatch reaches deep into the painful area to provide real relief at the source. Can be used 24/7. You won't feel anything but PAIN RELIEF. $$$ BACK GUARANTEE OFFER USA: http://actipatch.com 📷 #neckpainrelief #techneckrelief #painrelief #neckarthritisrelief #neckpain
ActiPatch SA February, 6 at 1:35 Am Struggling with chronic pain? 🤕 ActiPatch® pain-relief device is clinically proven to relieve muscle and joint pain!¹?³ ✅ Ideal for arthritis, back pain, knee pain, fibromyalgia, and more.² 🔍 Targeted, long-lasting pain relief in just 2-3 hours.¹ 🔋 Lasts up to 720 hours for continuous comfort. 🚀 Small & lightweight.¹ Say goodbye to bulky equipment! Get back to feeling your best with ActiPatch®, available at Dis-Chem Pharmacies, Clicks and leading pharmacies nationwide. #ActiPatch #DrugFree #PainRelief #PainManagement #ChronicPainManagement #JointPainRelief #SportsInjuryRelief#BackPainRelief https://www.facebook.com/watch/?v=1124676815379216
ActiPatch® @ActiPatch Get the sleep you deserve with relief from ActiPatch! ActiPatch doesn't just put a band-aid on pain. It dives deep with its Pulsed Shortwave Therapy & takes on pain at its root for sustained relief! Order at: http://actipatch.com FREE SHIPPING. #painmanagement #painfreesleep
ActiPatch SA If tennis injuries are following you off the court, ActiPatch® can help lessen your downtime by serving up clinically proven joint and muscle pain relief!²,³ 🎾 Drug free¹ 🎾 Can be worn 24/7, even during physical activity and sweating¹ https://www.facebook.com/share/v/jdHfKoc7x7dB...tid=CYgPv5
Once, pay ATTENTION Everyone -- NOT if, imo, NHL, NFL, NBA, WBA, MLB, PGA, Lacrosse, etc...... adopts Actipatch as a must protocol, after all thoseHITS, CHECKS, TRIPS, LIGAMENT PULLS/RIPS, etc.......Possibilities are ENDLESS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!! ActiPatch® technology, your best ally ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints. https://gymprotips.com/tips-to-speed-recovery-from-injury/
BioElectronics Corporation’s Post View organization page for BioElectronics Corporation BioElectronics Corporation 3,331 followers
Both NSAID therapy and neuromodulation therapy using PSWT resulted in statistically and clinically important reductions in pain level and improvement in functionality associated with cervical osteoarthritis, when used for 4 weeks. However, the PSWT intervention demonstrated superior improvements in all outcome measures when compared to the etoricoxib therapy arm, including patient satisfaction rating and decreased use of rescue pain medication. These results suggest that neuromodulation using PSWT may be a superior pain treatment option, when compared to COX-2 NSAIDS for neck osteoarthritis, and as well, represents a non-invasive, non-pharmacologic treatment option.
Product samples are available to licensed medical care providers in the USA. Request via email - info[ @newbie00
MD Medical MD Medical is the fastest growing medical company in kuwait. SIster Company @socheck_kuwait Kuwait, Hawally Governorate, Salmiya, Block 2, Abdullah Bin Masoud Street, Al-Ras Tower, Floor 3, Office No.B3, Kuwait City 13091 https://www.instagram.com/mdmedicalco/
Veterans, connect with us to learn more about RecoveryRx® New PAIN RELIEF TECHNOLOGY at the push of a button!!! https://kellycovemobility.com/rrx/
BIEL$$$ RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!! https://youtu.be/jljs7QPX7KE
------------------------------------------------------------------------------------- This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment: (https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
INTRODUCING RecoveryRx Veterinary Drug-Free Pain Relief Device For Indoor and Outdoor Pets https://rrxvet.carrd.co/ BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Vet Recovery RX "An innovation in drug-free pain and edema management. RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy https://vetphysiodevon.com/vet-recovery-rxdevice which utilizes radio-frequency electromagnetic energy to modulate nerve activity" #:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity
Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness. Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions. https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst
"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy." https://www.glebevets.co.uk/services/physiotherapy/
Once, pay ATTENTION Everyone -- NOT if, imo, NHL, NFL, NBA, WBA, MLB, PGA, Lacrosse, etc...... adopts Actipatch as a must protocol, after all those HITS, CHECKS, TRIPS, LIGAMENT PULLS/RIPS, etc.......Possibilities are ENDLESS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!! ActiPatch® technology, your best ally ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints. https://gymprotips.com/tips-to-speed-recovery-from-injury/ BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$[
1000 Veterinarian Clinics (USA): Conservatively assume each office orders 10/mo. @ $100 each for BIEL (Vet sells for $200, a bargain compared to Assisi): 1000 x 100 x 10 x 12 = $12,000,000 rev/year.
100 VA Hospitals: Conservatively assume each hospital orders 100 RecoveryRx per month ($100 each for BIEL): 100 x 100 x 100 x 12 = $12,000,000 rev/year.
Using profit = $20 mil and P/E = 100: PPS = .08!
Additional revenue could be generated from new FDA clearances, vagus nerve patent, NPA, UK/Australia contract rumor, etc. Initiating a stock buyback program after all of the loans are paid off would propel the pps much higher (pps = .25 to $1?).
ADDITIONAL CATALYST: Here are some additional numbers using Taiwan as a catalyst, using beacham's conservative numbers of 1% market penetration w/$10 profit/unit yields $43 million revenue:
$3 million = break even, cash flow positive: pps = .01. Each additional $2.5 million/year should result in an additional .01 increase in pps (P/E = 100).
For revenue = $43 million, profit = $40 million (and applying the tax loss carryforward), resulting pps = .16 (P/E = 100) .32 (P/E = 200) .48 (P/E = 300)
However, there are several factors that indicate this estimate might be extremely conservative, such as: 1) Taiwan appears to be using the RecoveryRx (requires doctor approval) version of Actipatch (OTC), which would have a higher profit than $10/unit. 2) market penetration will likely be higher than 1%.
Therefore, a case could be made for increasing the above estimates 10-fold or more (although tax would then need to be factored in). Now factor in the VA, veterinary, and other rumored contracts (if they materialize), and you're taking some serious money!
ANOTHER BIEL VALUATION MEASURE: QUBT hit $27/share recently, even though their revenue last year ($358k) was half that of BIEL ($715k). Accounting for the difference in outstanding shares (25 bil vs 100 mil), BIEL pps = .10 is the equivalent valuation to QUBT = $27/share. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175566191
Market Data 
Markets 
AI
